Solid Government Backing Spurs Global Inhalation and Nasal Spray Generic Drugs Market to Reach US$35.5 bn by 2023 The global inhalation and nasal spray generic drugs market is expected to reach US$35.5 bn by the end of 2023. This market was recorded at US$21.8 bn in 2014. Owing to a diverse set of positive forces, this market is expanding at a CAGR of 5.5% within a forecast period from 2015 to 2023, as stated in a research report released by Transparency Market Research.
The leading market intelligence firm has recently published the report, titled “Inhalation and Nasal Spray Generic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 2023.� The report uses proven research methodologies and credible data sources to thoroughly examine the market to devise a forecast analysis for it. According to the report, the primary driver for the global inhalation and nasal spray generic drugs market is the growing prevalence of respiratory disorders. An increasing number of patients are being diagnosed with medical problems such as COPD, asthma, and other and even fatal diseases. Government bodies have always had an eye out for the rising number of patients, leading to a large number of governments providing swift and strong support to their national healthcare industries for the development and proliferation of improved treatments.